|  |  | avg MAT titres ± SD (log2), weeks after first vaccination | |||
---|---|---|---|---|---|---|
n | Group | Challenge with | 0 | 4 | 6 | 10 |
9 | vaccine | sv Canicola | <2 | <2 | 9.6 ± 2.0 | 9.6 ± 1.3 |
10 | control | sg Canicola | <2 | <2 | <2 | 10.3 ± 1.1 |
10 | vaccine | sv Copenhageni | <2 | <2 | 3.8 ± 1.2 | 9.6 ± 1.0 |
10 | control | sg lcterohaemorrhagiae | <2 | <2 | <2 | 10.3 ± 0.7 |
10 | vaccine | sv lcterohaemorrhagiae | <2 | <2 | <2 | 91 ± 3.3 |
10 | control | sg lcterohaemorrhagiae | <2 | <2 | <2 | 8.7 ± 1.4 |
10 | vaccine | sv Bananal / Liangguan | <2 | <2 | 6.9 ± 1.4 | 9.3 ± 0.8 |
9 | control | sg Grippotyphosa | <2 | <2 | <2 | 91 ± 0.8 |
8 | vaccine | sv Grippotyphosa | <2 | <2 | 4.6 ± 2.4 | 7.6 ± 1.3 |
10 | control | sg Grippotyphosa | <2 | <2 | <2 | 2.0 ± 1.8 |
10 | vaccine | sv Bratislava | <2 | 6.9 ± 1.2 | 10.4 ± 0.8 | 10.5 ± 1.1 |
9 | control | sg Australis | <2 | <2 | <2 | 9.9 ± 1.2 |
9 | vaccine | sv Pomona | <2 | <2 | 5.0 ± 4.0 | 6.7 ± 3.2 |
10 | control | sg Pomona | <2 | <2 | <2 | 9.6 ± 0.8 |
10 | vaccine | sv Vughia | <2 | <2 | <2 | 8.5 ± 0.8 |
10 | control | sg Tarassovi | <2 | <2 | <2 | 9.5 ± 1.0 |
10 | vaccine | sv Tarassovi | <2 | <2 | 2.0 ± 3.2 | 8.0 ± 1.3 |
10 | control | sg Tarassovi | <2 | <2 | <2 | 4.3 ± 1.3 |